The risk of hypocalcaemia after denosumab administration
Authors:
- 23 February 2026
- journal article
- letter
- Published by Springer Nature in Osteoporosis International
- Vol. 37 (4) , 1007-1008
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Hypocalcemia following denosumab in osteoporosis: Incidence and risk factors in a Saudi cohortOsteoporosis International, 2026
- The 2024 UK clinical guideline for the prevention and treatment of osteoporosisArchives of Osteoporosis, 2025
- Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysisJournal of Pharmaceutical Health Care and Sciences, 2024
- Secondary hyperparathyroidism: Predictors and relationship with vitamin D status, bone turnover markers and bone mineral densityBone, 2024
- A Simple-to-Use Score for Identifying Individuals at High Risk of Denosumab-Associated Hypocalcemia in Postmenopausal Osteoporosis: A Real-World Cohort StudyCalcified Tissue International, 2020
- Effectiveness of thiazides on serum and urinary calcium levels and bone mineral density in patients with osteoporosis: a systematic review and meta-analysisDrug Design, Development and Therapy, 2018